BioEclipse Therapeutics
PrivateLast Round
Grant
Apr 26, 2022
Total Funding Raised
$15.7M
Momentum Score
25 /100
Company Overview
BioEclipse Therapeutics is a biotechnology company that develops immuno-oncology therapeutics designed to kill tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioEclipse Therapeutics Comps
Public and private peers based on sector, stage, and business model.
BioEclipse Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 26, 2022 | ||||
| Series A Extension | Jun 24, 2019 |
Key People
Founding team and executive leadership
BioEclipse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Revelis Capital Group | Series A Extension |
| Foothill Ventures | Series A Extension |
| DEFTA Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 61% MoM.
BioEclipse Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioEclipse Therapeutics's valuation, stock price, and market status.
